1 / 4

Point-of-Care Infectious Disease Diagnostics Market Research Report with Revenue

Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities.<br>

rushi12
Télécharger la présentation

Point-of-Care Infectious Disease Diagnostics Market Research Report with Revenue

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. POC Infectious Disease Diagnostics Market - POC Infectious Disease Diagnostics Market - Size, Share, Growth, Outlook, and Opportunity Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Analysis, 2018-2026 Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/63 Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of- care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth. Advances in technology of point of care diagnostics is expected to support the growth of the point of care infectious disease diagnostics market

  2. Centralized laboratory testing is the gold standard and has established in biochemistry, hematology, and diagnostics. Point-of-care diagnostic offers various advantages such as ease of use in remote areas, technological advancements, and lowered price points. Small handheld point-of-care devices are portable and can be used by patients themselves. These tests use fingerstick or capillary samples, which are directly applied to instrument and avoid need of sample containers. Technologies such as lateral flow, various molecular assays integrated with point-of-care have changed the outlook of point-of-care diagnostics. For instance, products offered by leading manufacturers such as Alere and Roche are immunoassays, which are cost- effective and provide rapid results. Furthermore, in 2014, Becton, Dickinson, and Company offered point-of-care system BD FACSPresto for HIV/AIDS. It offers percentage results of CD4 T lymphocytes and hemoglobin concentration. Moreover, Infectious Disease Research Institute (IDRI) developed a fusion antigen in January 2017, which is used as a part of diagnostic test manufactured by InBios International, Inc. for Chagas disease. Report includes chapters which deeply display the following deliverable about industry : • POC Infectious Disease Diagnostics Market Research Objective and Assumption • POC Infectious Disease Diagnostics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • POC Infectious Disease Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global POC Infectious Disease Diagnostics Market, By Regions • POC Infectious Disease Diagnostics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • POC Infectious Disease Diagnostics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • POC Infectious Disease Diagnostics Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • POC Infectious Disease Diagnostics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion

  3. Major players operating in the point of care infectious disease diagnostics market include Danaher Corporation, Abbott Laboratories, Alcon Laboratories, Inc., Hoffman- La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/63 Detailed Segmentation: Global Point of Care Infectious Disease Diagnostics Market, By Technology: • Lateral Flow • Agglutination Assays • Flow-Through • Solid Phase Global Point of Care Infectious Disease Diagnostics Market, By Application: • HIV • Tropical Disease • Liver Disease • Inflammatory Disease • Respiratory Disease • Hospital Associated Infections (HAIs) • Sexual Health Disorders • Others Global Point of Care Infectious Disease Diagnostics Market, By End User: • Hospitals • Diagnostic Laboratories • Home-Care Settings • Others Global Point of Care Infectious Disease Diagnostics Market, By Geography: • North America • • • • Europe • Asia Pacific • Latin America • Middle East • Africa •

  4. About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related